Synthetic/secreting and apoptotic phenotypes in renal biopsy tissues from hypertensive nephrosclerosis patients

Hypertension Research

Volumn 29, Issue 8, 2006, Pages 573-580

  Kimura, Noriyo ^a   Yonemoto, Satomi ^b   Machiguchi, Toshihiko ^a   Li, Xuan ^a   Kimura, Hideki ^a   Yoshida, Haruyoshi ^a  

^a UNIVERSITY OF FUKUI HOSPITAL   (Japan)

^b Kitano Hospital   (Japan)

Author keywords

smooth muscle actin; Bax; Bcl 2; Collagen type III

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTIHYPERTENSIVE AGENT; COLLAGEN TYPE 3; CREATININE; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; FEMALE; FIBROSING ALVEOLITIS; FREQUENCY ANALYSIS; GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; MALE; MEAN ARTERIAL PRESSURE; MESANGIUM CELL; MULTIVARIATE ANALYSIS; NEPHROSCLEROSIS; PHENOTYPE; PODOCYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS;

ACTINS; ADULT; AGED; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL MARKERS; COLLAGEN TYPE III; FEMALE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; NEPHROSCLEROSIS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33748935363     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.573     Document Type: Article

References (17)

1. Helmcben U, Wenzel UO: Benign and malignant nephrosclerosis and renovascular disease, in Tisher CC, Brenner BM: Renal Pathology. Philadelphia, Lippincott, 1994, pp 1201-1236.
2. Olson JL: Hypertension: essential and secondary forms, in Jennette JC, Olson JL, Schwartz MM, Silva FG: Heptinstall's Pathology of the Kidney, 5th ed. Philadelphia, Lippincott, 1998, pp 943-1001.
3. Nakaya H, Sasamura H, Kitamura Y, et al: Effects of angiotensin inhibitors on renal injury and angiotensin receptor expression in early hypertensive nephrosclerosis. Hypertens Res 1999; 22: 303-312.
4. Luft FC: Hypertensive nephrosclerosis: update. Curr Opin Nephrol Hypertens 2004; 13: 147-154.
5. Inada H, Ono H, Minami J, Ishimitsu T, Matsuoka H: Nipradilol prevents L-NAME-exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR. Hypertens Res 2002; 25: 433-440.
6. Rupprecht HD, Schocklmann HO, Sterzel RB: Glomerular mesangial cells, in Neilson EG, Couser WG: Immunologic Renal Disease, 2nd ed. Philadelphia, Lippincott, 2001, pp 657-691.
7. Sanders PW, Wang PX: Activation of the Fas/Fas ligand pathway in hypertensive renal disease in Dahl/Rapp rats. BMC Nephrol 2002; 3: 1.
8. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Apoptosis in glomerular sclerosis. Kidney Int 1996; 49: 103-111.
9. Ono H, Ono Y, Takanohashi A, Matsuoka H, Frohlich ED: Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats. Hypertension 2001; 38: 1300-1306.
10. Ono H, Saitoh M, Ono Y, Ishimitu T, Matsuoka H: Imidapril improves L-NAME-exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats. J Hypertens 2004; 22: 1389-1395.
11. Ying WZ, Wang PX, Sanders PW: Induction of apoptosis during development of hypertensive nephrosclerosis. Kidney Int 2000; 58: 2007-2017.
12. Ying WZ, Sanders PW: Cytochrome c mediates apoptosis in hypertensive nephrosclerosis in Dahl/Rapp rats. Kidney Int 2001; 59: 662-672.
13. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
14. Fogo A, Breyer JA, Smith MC, et al, AASK Pilot Study Investigators: Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. Kidney Int 1997; 51: 244-252.
15. Takebayashi S, Kiyoshi Y, Hisano S, et al: Benign nephrosclerosis: incidence, morphology and prognosis. Clin Nephrol 2001; 55: 349-356.
16. Kritz W, Kobayashi N, Elger M: New aspects of podocyte structure, function, and pathology. Clin Exp Nephrol 1998; 2: 85-99.
17. Kretzler M, Koeppen-Hagemann I, Kriz W: Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat. Virchows Arch 1994; 425: 181-193.